中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
177-178
,共2页
原发性IgA肾病%雷公藤多甙片%盐酸贝那普利%临床疗效
原髮性IgA腎病%雷公籐多甙片%鹽痠貝那普利%臨床療效
원발성IgA신병%뢰공등다대편%염산패나보리%림상료효
IgA nephropathy%Tripterygium wilfordii glycosides tablets%Benazepril hydrochloride%Clinical effect
目的：观察雷公藤多甙片与盐酸贝那普利联合应用治疗原发性IgA肾病的临床疗效。方法选择我院86例原发性IgA肾病患者为研究对象，随机将其分成实验组和对照组，实验组42例，对照组44例，实验组患者采用雷公藤多甙片与盐酸贝那普利结合的治疗方式，对照组患者采取常规的治疗方式。结果实验组患者的治疗总有效率为85.71%，对照组患者的治疗总有效率为65.90%。差异有统计学意义（P<0.05）。结论雷公藤多甙片与盐酸贝那普利联合应用治疗原发性IgA肾病疗效显著。
目的：觀察雷公籐多甙片與鹽痠貝那普利聯閤應用治療原髮性IgA腎病的臨床療效。方法選擇我院86例原髮性IgA腎病患者為研究對象，隨機將其分成實驗組和對照組，實驗組42例，對照組44例，實驗組患者採用雷公籐多甙片與鹽痠貝那普利結閤的治療方式，對照組患者採取常規的治療方式。結果實驗組患者的治療總有效率為85.71%，對照組患者的治療總有效率為65.90%。差異有統計學意義（P<0.05）。結論雷公籐多甙片與鹽痠貝那普利聯閤應用治療原髮性IgA腎病療效顯著。
목적：관찰뢰공등다대편여염산패나보리연합응용치료원발성IgA신병적림상료효。방법선택아원86례원발성IgA신병환자위연구대상，수궤장기분성실험조화대조조，실험조42례，대조조44례，실험조환자채용뢰공등다대편여염산패나보리결합적치료방식，대조조환자채취상규적치료방식。결과실험조환자적치료총유효솔위85.71%，대조조환자적치료총유효솔위65.90%。차이유통계학의의（P<0.05）。결론뢰공등다대편여염산패나보리연합응용치료원발성IgA신병료효현저。
Objective To observe the clinical ef ect of tripterygium wilfordi glycosides tablets and benazepril hydrochloride for the treatment of IgA nephropathy.Methods 86 cases of IgA nephropathy were selected in our hospital received as an object of observation according to randomly divided into the treatment group(42 cases) and the control group(44 cases). The control group was given routine treatment.The treatment group was given tripterygium wilfordi glycosides tablets and benazepril hydrochloride.Results The total ef iciency of the treatment group was 85.71%,while the control group was 65.90%(P<0.05). Dif erences were statistical y significant. Conclusion Tripterygium wilfordi glycosides tablets and benazepril hydrochloride has obvious curative ef ect to IgA nephropathy.
